ID   PRDX2_HUMAN             Reviewed;         198 AA.
AC   P32119; A8K0C0; P31945; P32118; P35701; Q6FHG4; Q92763; Q9UC23;
DT   01-OCT-1993, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 5.
DT   10-MAY-2017, entry version 198.
DE   RecName: Full=Peroxiredoxin-2;
DE            EC=1.11.1.15;
DE   AltName: Full=Natural killer cell-enhancing factor B;
DE            Short=NKEF-B;
DE   AltName: Full=PRP;
DE   AltName: Full=Thiol-specific antioxidant protein;
DE            Short=TSA;
DE   AltName: Full=Thioredoxin peroxidase 1;
DE   AltName: Full=Thioredoxin-dependent peroxide reductase 1;
GN   Name=PRDX2; Synonyms=NKEFB, TDPX1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=8144038; DOI=10.1016/0378-1119(94)90558-4;
RA   Lim Y.-S., Cha M.-K., Kim H.-K., Kim I.-H.;
RT   "The thiol-specific antioxidant protein from human brain: gene cloning
RT   and analysis of conserved cysteine regions.";
RL   Gene 140:279-284(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8026862; DOI=10.1007/BF00188176;
RA   Shau H., Butterfield L.H., Chiu R., Kim A.;
RT   "Cloning and sequence analysis of candidate human natural killer-
RT   enhancing factor genes.";
RL   Immunogenetics 40:129-134(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S.,
RA   Neubert P., Kstrang K., Schatten R., Shen B., Henze S., Mar W.,
RA   Korn B., Zuo D., Hu Y., LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT GLU-153.
RG   NIEHS SNPs program;
RL   Submitted (OCT-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Hypothalamus, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 8-26; 67-135 AND 140-150, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Vishwanath V., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [10]
RP   PROTEIN SEQUENCE OF 8-24, AND CATALYTIC ACTIVITY.
RC   TISSUE=Erythrocyte;
RX   PubMed=8554614; DOI=10.1006/bbrc.1995.2856;
RA   Cha M.-K., Kim I.-H.;
RT   "Thioredoxin-linked peroxidase from human red blood cell: evidence for
RT   the existence of thioredoxin and thioredoxin reductase in human red
RT   blood cell.";
RL   Biochem. Biophys. Res. Commun. 217:900-907(1995).
RN   [11]
RP   PROTEIN SEQUENCE OF 17-26; 93-103 AND 120-129.
RC   TISSUE=Erythrocyte;
RX   PubMed=8313871; DOI=10.1002/elps.11501401183;
RA   Golaz O., Hughes G.J., Frutiger S., Paquet N., Bairoch A.,
RA   Pasquali C., Sanchez J.-C., Tissot J.-D., Appel R.D., Walzer C.,
RA   Balant L., Hochstrasser D.F.;
RT   "Plasma and red blood cell protein maps: update 1993.";
RL   Electrophoresis 14:1223-1231(1993).
RN   [12]
RP   PROTEIN SEQUENCE OF 17-26; 111-135 AND 140-157.
RC   TISSUE=Colon carcinoma;
RX   PubMed=9150948; DOI=10.1002/elps.1150180344;
RA   Ji H., Reid G.E., Moritz R.L., Eddes J.S., Burgess A.W., Simpson R.J.;
RT   "A two-dimensional gel database of human colon carcinoma proteins.";
RL   Electrophoresis 18:605-613(1997).
RN   [13]
RP   PROTEIN SEQUENCE OF 17-25; 140-150 AND 163-185.
RC   TISSUE=Keratinocyte;
RX   PubMed=1286667; DOI=10.1002/elps.11501301199;
RA   Rasmussen H.H., van Damme J., Puype M., Gesser B., Celis J.E.,
RA   Vandekerckhove J.;
RT   "Microsequences of 145 proteins recorded in the two-dimensional gel
RT   protein database of normal human epidermal keratinocytes.";
RL   Electrophoresis 13:960-969(1992).
RN   [14]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 35-198 (ISOFORM 1).
RA   Oberbaeumer I.;
RL   Submitted (OCT-1996) to the EMBL/GenBank/DDBJ databases.
RN   [15]
RP   OVEROXIDATION AT CYS-51.
RX   PubMed=11904290; DOI=10.1074/jbc.M106585200;
RA   Rabilloud T., Heller M., Gasnier F., Luche S., Rey C., Aebersold R.,
RA   Benahmed M., Louisot P., Lunardi J.;
RT   "Proteomics analysis of cellular response to oxidative stress.
RT   Evidence for in vivo overoxidation of peroxiredoxins at their active
RT   site.";
RL   J. Biol. Chem. 277:19396-19401(2002).
RN   [16]
RP   RETROREDUCTION OF CYS-51, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=12853451; DOI=10.1074/jbc.M305161200;
RA   Chevallet M., Wagner E., Luche S., van Dorsselaer A., Leize-Wagner E.,
RA   Rabilloud T.;
RT   "Regeneration of peroxiredoxins during recovery after oxidative
RT   stress: only some overoxidized peroxiredoxins can be reduced during
RT   recovery after oxidative stress.";
RL   J. Biol. Chem. 278:37146-37153(2003).
RN   [17]
RP   INTERACTION WITH TIPIN.
RX   PubMed=17141802; DOI=10.1016/j.jmb.2006.10.097;
RA   Gotter A.L., Suppa C., Emanuel B.S.;
RT   "Mammalian TIMELESS and Tipin are evolutionarily conserved replication
RT   fork-associated factors.";
RL   J. Mol. Biol. 366:36-52(2007).
RN   [18]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22905912; DOI=10.1021/pr300539b;
RA   Rosenow A., Noben J.P., Jocken J., Kallendrusch S.,
RA   Fischer-Posovszky P., Mariman E.C., Renes J.;
RT   "Resveratrol-induced changes of the human adipocyte secretion
RT   profile.";
RL   J. Proteome Res. 11:4733-4743(2012).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-112 AND THR-182, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 1-198.
RX   PubMed=10873855; DOI=10.1016/S0969-2126(00)00147-7;
RA   Schroeder E., Littlechild J.A., Lebedev A.A., Errington N.,
RA   Vagin A.A., Isupov M.N.;
RT   "Crystal structure of decameric 2-Cys peroxiredoxin from human
RT   erythrocytes at 1.7 A resolution.";
RL   Structure 8:605-615(2000).
CC   -!- FUNCTION: Involved in redox regulation of the cell. Reduces
CC       peroxides with reducing equivalents provided through the
CC       thioredoxin system. It is not able to receive electrons from
CC       glutaredoxin. May play an important role in eliminating peroxides
CC       generated during metabolism. Might participate in the signaling
CC       cascades of growth factors and tumor necrosis factor-alpha by
CC       regulating the intracellular concentrations of H(2)O(2).
CC   -!- CATALYTIC ACTIVITY: 2 R'-SH + ROOH = R'-S-S-R' + H(2)O + ROH.
CC       {ECO:0000269|PubMed:8554614}.
CC   -!- SUBUNIT: Homodimer; disulfide-linked, upon oxidation. May be found
CC       as a toroid-shaped decamer composed of 5 dimers, depending on pH
CC       and calcium concentration. Interacts with TIPIN.
CC       {ECO:0000269|PubMed:17141802}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P32119-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P32119-2; Sequence=VSP_042924;
CC         Note=No experimental confirmation available. Due to intron
CC         retention. May be produced at very low levels due to a premature
CC         stop codon in the mRNA, leading to nonsense-mediated mRNA
CC         decay.;
CC   -!- MISCELLANEOUS: The active site is the redox-active Cys-51 oxidized
CC       to Cys-SOH. Cys-SOH rapidly reacts with Cys-172-SH of the other
CC       subunit to form an intermolecular disulfide with a concomitant
CC       homodimer formation. The enzyme may be subsequently regenerated by
CC       reduction of the disulfide by thioredoxin.
CC   -!- MISCELLANEOUS: Inactivated upon oxidative stress by overoxidation
CC       of Cys-51 to Cys-SO(2)H and Cys-SO(3)H. Cys-SO(2)H is retroreduced
CC       to Cys-SOH after removal of H(2)O(2), while Cys-SO(3)H may be
CC       irreversibly oxidized.
CC   -!- SIMILARITY: Belongs to the AhpC/TSA family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/prdx2/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z22548; CAA80269.1; -; mRNA.
DR   EMBL; L19185; AAA50465.1; -; mRNA.
DR   EMBL; CR450356; CAG29352.1; -; mRNA.
DR   EMBL; CR541789; CAG46588.1; -; mRNA.
DR   EMBL; AK289485; BAF82174.1; -; mRNA.
DR   EMBL; DQ231563; ABB02182.1; -; Genomic_DNA.
DR   EMBL; AC018761; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471106; EAW84311.1; -; Genomic_DNA.
DR   EMBL; BC000452; AAH00452.1; -; mRNA.
DR   EMBL; BC003022; AAH03022.1; -; mRNA.
DR   EMBL; BC039428; AAH39428.1; -; mRNA.
DR   EMBL; X82321; CAA57764.1; -; mRNA.
DR   CCDS; CCDS12281.1; -. [P32119-1]
DR   PIR; I68897; I68897.
DR   RefSeq; NP_005800.3; NM_005809.5. [P32119-1]
DR   UniGene; Hs.432121; -.
DR   PDB; 1QMV; X-ray; 1.70 A; A/B/C/D/E/F/G/H/I/J=2-198.
DR   PDB; 5B8A; X-ray; 2.70 A; A/B/C/D/E/F/G/H/I/J=46-198.
DR   PDB; 5B8B; X-ray; 3.10 A; A/B/C/D/E/F/G/H/I/J=46-163, A/B/C/D/E/F/G/H/I/J=80-198.
DR   PDBsum; 1QMV; -.
DR   PDBsum; 5B8A; -.
DR   PDBsum; 5B8B; -.
DR   ProteinModelPortal; P32119; -.
DR   SMR; P32119; -.
DR   BioGrid; 112860; 99.
DR   DIP; DIP-39882N; -.
DR   IntAct; P32119; 44.
DR   MINT; MINT-3012817; -.
DR   STRING; 9606.ENSP00000301522; -.
DR   DrugBank; DB02153; 3-Sulfinoalanine.
DR   DrugBank; DB04048; N-Carbamoyl-Alanine.
DR   PeroxiBase; 4475; Hs2CysPrx02.
DR   iPTMnet; P32119; -.
DR   PhosphoSitePlus; P32119; -.
DR   SwissPalm; P32119; -.
DR   DMDM; 2507169; -.
DR   DOSAC-COBS-2DPAGE; P32119; -.
DR   OGP; P32119; -.
DR   REPRODUCTION-2DPAGE; IPI00027350; -.
DR   SWISS-2DPAGE; P32119; -.
DR   UCD-2DPAGE; P32119; -.
DR   EPD; P32119; -.
DR   PaxDb; P32119; -.
DR   PeptideAtlas; P32119; -.
DR   PRIDE; P32119; -.
DR   TopDownProteomics; P32119-1; -. [P32119-1]
DR   DNASU; 7001; -.
DR   Ensembl; ENST00000301522; ENSP00000301522; ENSG00000167815. [P32119-1]
DR   GeneID; 7001; -.
DR   KEGG; hsa:7001; -.
DR   CTD; 7001; -.
DR   DisGeNET; 7001; -.
DR   GeneCards; PRDX2; -.
DR   HGNC; HGNC:9353; PRDX2.
DR   HPA; CAB008713; -.
DR   MIM; 600538; gene.
DR   neXtProt; NX_P32119; -.
DR   OpenTargets; ENSG00000167815; -.
DR   PharmGKB; PA33723; -.
DR   eggNOG; KOG0852; Eukaryota.
DR   eggNOG; COG0450; LUCA.
DR   GeneTree; ENSGT00390000004653; -.
DR   HOGENOM; HOG000022343; -.
DR   HOVERGEN; HBG000286; -.
DR   InParanoid; P32119; -.
DR   KO; K03386; -.
DR   OMA; DYEVVHE; -.
DR   OrthoDB; EOG091G0IE5; -.
DR   PhylomeDB; P32119; -.
DR   TreeFam; TF105181; -.
DR   BRENDA; 1.11.1.15; 2681.
DR   Reactome; R-HSA-3299685; Detoxification of Reactive Oxygen Species.
DR   Reactome; R-HSA-5628897; TP53 Regulates Metabolic Genes.
DR   Reactome; R-HSA-8862803; Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models.
DR   ChiTaRS; PRDX2; human.
DR   EvolutionaryTrace; P32119; -.
DR   GeneWiki; Peroxiredoxin_2; -.
DR   GenomeRNAi; 7001; -.
DR   PRO; PR:P32119; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000167815; -.
DR   CleanEx; HS_PRDX2; -.
DR   ExpressionAtlas; P32119; baseline and differential.
DR   Genevisible; P32119; HS.
DR   GO; GO:0005737; C:cytoplasm; TAS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0016209; F:antioxidant activity; IDA:UniProtKB.
DR   GO; GO:0008379; F:thioredoxin peroxidase activity; IDA:UniProtKB.
DR   GO; GO:0045454; P:cell redox homeostasis; IEA:InterPro.
DR   GO; GO:0034599; P:cellular response to oxidative stress; IDA:BHF-UCL.
DR   GO; GO:0042744; P:hydrogen peroxide catabolic process; TAS:BHF-UCL.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; TAS:UniProtKB.
DR   GO; GO:0042981; P:regulation of apoptotic process; IMP:UniProtKB.
DR   GO; GO:0019430; P:removal of superoxide radicals; IDA:BHF-UCL.
DR   GO; GO:0006979; P:response to oxidative stress; IMP:UniProtKB.
DR   GO; GO:0000302; P:response to reactive oxygen species; TAS:Reactome.
DR   InterPro; IPR000866; AhpC/TSA.
DR   InterPro; IPR024706; Peroxiredoxin_AhpC-typ.
DR   InterPro; IPR019479; Peroxiredoxin_C.
DR   InterPro; IPR033046; PRDX2.
DR   InterPro; IPR012336; Thioredoxin-like_fold.
DR   InterPro; IPR013766; Thioredoxin_domain.
DR   PANTHER; PTHR10681:SF136; PTHR10681:SF136; 1.
DR   Pfam; PF10417; 1-cysPrx_C; 1.
DR   Pfam; PF00578; AhpC-TSA; 1.
DR   PIRSF; PIRSF000239; AHPC; 1.
DR   SUPFAM; SSF52833; SSF52833; 1.
DR   PROSITE; PS51352; THIOREDOXIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Antioxidant;
KW   Complete proteome; Cytoplasm; Direct protein sequencing;
KW   Disulfide bond; Oxidoreductase; Peroxidase; Phosphoprotein;
KW   Polymorphism; Redox-active center; Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330}.
FT   CHAIN         2    198       Peroxiredoxin-2.
FT                                /FTId=PRO_0000135080.
FT   DOMAIN        6    164       Thioredoxin. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00691}.
FT   ACT_SITE     51     51       Cysteine sulfenic acid (-SOH)
FT                                intermediate.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   MOD_RES     112    112       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     182    182       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   DISULFID     51     51       Interchain (with C-172); in linked form.
FT                                {ECO:0000250}.
FT   DISULFID    172    172       Interchain (with C-51); in linked form.
FT                                {ECO:0000250}.
FT   VAR_SEQ      87    198       INTPRKEGGLGPLNIPLLADVTRRLSEDYGVLKTDEGIAYR
FT                                GLFIIDGKGVLRQITVNDLPVGRSVDEALRLVQAFQYTDEH
FT                                GEVCPAGWKPGSDTIKPNVDDSKEYFSKHN -> YEQGPKR
FT                                EVAAKLTPSGPSSVASWPLLNLWNLRFPIVKIMETLPPKSL
FT                                RMMTVISI (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_042924.
FT   VARIANT     153    153       D -> E (in dbSNP:rs34012472).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_025051.
FT   CONFLICT     59     66       SNRAEDFR -> TTVKRTSA (in Ref. 1;
FT                                CAA80269). {ECO:0000305}.
FT   CONFLICT     82     82       T -> N (in Ref. 2; AAA50465).
FT                                {ECO:0000305}.
FT   CONFLICT    105    105       A -> G (in Ref. 2; AAA50465).
FT                                {ECO:0000305}.
FT   CONFLICT    120    120       T -> N (in Ref. 1; CAA80269).
FT                                {ECO:0000305}.
FT   CONFLICT    126    127       YR -> TT (in Ref. 11; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    175    175       G -> A (in Ref. 1; CAA80269).
FT                                {ECO:0000305}.
FT   CONFLICT    180    180       S -> R (in Ref. 1; CAA80269).
FT                                {ECO:0000305}.
FT   STRAND       16     21       {ECO:0000244|PDB:1QMV}.
FT   STRAND       24     29       {ECO:0000244|PDB:1QMV}.
FT   HELIX        30     33       {ECO:0000244|PDB:1QMV}.
FT   STRAND       36     42       {ECO:0000244|PDB:1QMV}.
FT   HELIX        50     60       {ECO:0000244|PDB:1QMV}.
FT   HELIX        62     66       {ECO:0000244|PDB:1QMV}.
FT   TURN         67     69       {ECO:0000244|PDB:1QMV}.
FT   STRAND       70     78       {ECO:0000244|PDB:1QMV}.
FT   HELIX        80     87       {ECO:0000244|PDB:1QMV}.
FT   HELIX        91     93       {ECO:0000244|PDB:1QMV}.
FT   STRAND      103    105       {ECO:0000244|PDB:1QMV}.
FT   HELIX       110    114       {ECO:0000244|PDB:1QMV}.
FT   TURN        120    122       {ECO:0000244|PDB:1QMV}.
FT   STRAND      127    132       {ECO:0000244|PDB:1QMV}.
FT   STRAND      136    144       {ECO:0000244|PDB:1QMV}.
FT   HELIX       152    168       {ECO:0000244|PDB:1QMV}.
FT   HELIX       187    197       {ECO:0000244|PDB:1QMV}.
SQ   SEQUENCE   198 AA;  21892 MW;  1AC781D908B32B46 CRC64;
     MASGNARIGK PAPDFKATAV VDGAFKEVKL SDYKGKYVVL FFYPLDFTFV CPTEIIAFSN
     RAEDFRKLGC EVLGVSVDSQ FTHLAWINTP RKEGGLGPLN IPLLADVTRR LSEDYGVLKT
     DEGIAYRGLF IIDGKGVLRQ ITVNDLPVGR SVDEALRLVQ AFQYTDEHGE VCPAGWKPGS
     DTIKPNVDDS KEYFSKHN
//
